Literature DB >> 8702470

Tyrosine phosphorylation modulates the activity of clostridial neurotoxins.

A V Ferrer-Montiel1, J M Canaves, B R DasGupta, M C Wilson, M Montal.   

Abstract

Clostridial neurotoxins' metalloprotease domain selectively cleaves proteins implicated in the process of synaptic vesicle fusion with the plasma membrane and, accordingly, blocks neurotransmitter release into the synaptic cleft. Here we investigate the potential modulation of these neurotoxins by intracellular cascades triggered by environmental signals, which in turn may alter its activity on target substrates. We report that the nonreceptor tyrosine kinase Src phosphorylates botulinum neurotoxins A, B, and E and tetanus neurotoxin. Protein tyrosine phosphorylation of serotypes A and E dramatically increases both their catalytic activity and thermal stability, while dephosphorylation reverses the effect. This suggests that the biologically significant form of the neurotoxins inside neurons is phosphorylated. Indeed, in PC12 cells in which tyrosine kinases such as Src and PYK2 are highly abundant, stimulation by membrane depolarization in presence of extracellular calcium induces rapid and selective tyrosine phosphorylation of internalized light chain, the metalloprotease domain, of botulinum toxin A. These findings provide a conceptual framework to connect intracellular signaling pathways involving tyrosine kinases, G-proteins, phosphoinositides, and calcium with the action of botulinum neurotoxins in abrogating vesicle fusion and neurosecretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702470     DOI: 10.1074/jbc.271.31.18322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.

Authors:  Michael Adler; Harlan F Shafer; Heather A Manley; Brennie E Hackley; James D Nicholson; James E Keller; Michael C Goodnough
Journal:  J Protein Chem       Date:  2003-07

2.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

4.  Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.

Authors:  Audrey Fischer; Mauricio Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

5.  SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons.

Authors:  Erkan Kiris; James C Burnett; Jonathan E Nuss; Laura M Wanner; Brian D Peyser; Hao T Du; Glenn Y Gomba; Krishna P Kota; Rekha G Panchal; Rick Gussio; Christopher D Kane; Lino Tessarollo; Sina Bavari
Journal:  Neurotox Res       Date:  2015-03-18       Impact factor: 3.911

6.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

7.  Tyrosine phosphorylation of selected secretory carrier membrane proteins, SCAMP1 and SCAMP3, and association with the EGF receptor.

Authors:  T T Wu; J D Castle
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

8.  The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.

Authors:  Peter Silhár; Matthew A Lardy; Mark S Hixon; Charles B Shoemaker; Joseph T Barbieri; Anjali K Struss; Jenny M Lively; Sacha Javor; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2012-12-23       Impact factor: 4.345

9.  Cellular Protection of SNAP-25 against Botulinum Neurotoxin/A: Inhibition of Thioredoxin Reductase through a Suicide Substrate Mechanism.

Authors:  Hajime Seki; Song Xue; Sabine Pellett; Peter Šilhár; Eric A Johnson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2016-04-20       Impact factor: 15.419

10.  In cellulo phosphorylation induces pharmacological reprogramming of maurocalcin, a cell-penetrating venom peptide.

Authors:  Michel Ronjat; Wei Feng; Lucie Dardevet; Yao Dong; Sawsan Al Khoury; Franck C Chatelain; Virginie Vialla; Samir Chahboun; Florian Lesage; Hervé Darbon; Isaac N Pessah; Michel De Waard
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.